Wen Xu
- Hepatology top 5%
- Liver physiology and pathology 4
- Biological Psychiatry top 10%
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 3
- Cancer, Hypoxia, and Metabolism 3
- Molecular Biology top 10%
- Inflammasome and immune disorders 4
- RNA modifications and cancer 3
- Nephrology top 5%
-
- Cancer Cells and Metastasis 4
-
- Mycobacterium research and diagnosis 3
-
- Schizophrenia research and treatment 3
- Co-authors
- Yi HuangRongbin ZhouZhengfeng YinLu CaoJian LiaoHaihua QianYu ZhangYanming Zhou
- Partner nations
- ChinaPolandUnited States
In The Last Decade
Wen Xu
36 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Hepatology 202
- Biological Psychiatry 63
- Cancer Research 326
- Molecular Biology 1.2k
- Nephrology 118
Countries citing papers authored by Wen Xu
This map shows the geographic impact of Wen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Xu more than expected).
Fields of papers citing papers by Wen Xu
This network shows the impact of papers produced by Wen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Xu. The network helps show where Wen Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wen Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | NLRP3 inflammasome in neuroinflammation and central nervous system diseasesbreakdown → | 2025 | 49 |
| 3 | Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseasesbreakdown → | 2024 | 80 |
| 4 | 2023 | 10 | |
| 5 | 2022 | 26 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 25 | |
| 8 | NLRP3 inflammasome activation and cell deathbreakdown → | 2021 | 993 |
| 9 | 2020 | 54 | |
| 10 | 2019 | 3 | |
| 11 | 2018 | 21 | |
| 12 | 2018 | 32 | |
| 13 | 2012 | 8 | |
| 14 | 2012 | 57 | |
| 15 | 2011 | 128 | |
| 16 | 2011 | 229 | |
| 17 | 2011 | 48 | |
| 18 | 2009 | 54 | |
| 19 | 2009 | 2 | |
| 20 | 2009 | 77 |
About Wen Xu
Wen Xu is a scholar working on Hepatology, Cancer Research and Otorhinolaryngology, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include Liver physiology and pathology (4 papers), Cancer Cells and Metastasis (4 papers), Inflammasome and immune disorders (4 papers), Mycobacterium research and diagnosis (3 papers), Cancer Genomics and Diagnostics (3 papers), Schizophrenia research and treatment (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Hepatology (202 citations), Biological Psychiatry (63 citations) and Cancer Research (326 citations). Wen Xu has collaborated with scholars based in China, Poland and United States. Frequent co-authors include Yi Huang, Rongbin Zhou, Zhengfeng Yin, Lu Cao, Jian Liao, Haihua Qian, Yu Zhang, Yanming Zhou, Mengchao Wu and Ruixiu Zhang. Their work appears in journals such as Cancer Research, Brain Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.